More sessions you can’t miss
We identify ten more APP2021 sessions that you can’t afford to miss APP chairman Kos Sclavos continues his list of the twenty key sessions not to miss at the APP2021 …
What is Novavax, Australia’s third COVID vaccine option? And when will we get it?
Jamie Triccas, University of Sydney, looks at the third vaccine for which Australia has a deal As AstraZeneca is no longer the preferred vaccine for Australian adults under 50, attention …
What not to miss
What are the APP2021 sessions you can’t afford to miss? Here’s ten of the best APP chairman Kos Sclavos runs through the twenty key sessions not to miss at the …
Vaccinations 2021: what you need to know
Do pharmacists have indemnity cover for giving a COVID-19 vaccine? PDL has a full update on the 2021 vaccination season The 2021 vaccination season is upon us with many pharmacies …
Grin and bear it
The profession needs more empathy towards its own during times of sickness and difficulty, writes Chantelle Pennington For years in my career as a community pharmacist, I’ve spent a countless …
Blood clot risks: comparing the AstraZeneca vaccine and the contraceptive pill
Adam Taylor from Lancaster University takes a look at the clotting risk associated with AstraZeneca’s COVID-19 vaccine By the end of March, 79 cases of rare blood clots had been …
What is thrombocytopenia, the rare blood condition possibly linked to the AstraZeneca vaccine?
Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos, from Victoria University, take a look at the concerns over the AZ vaccine The federal government has asked Australia’s medical …
A balancing act between benefits and risks
Making sense of the latest vaccine news, by Hassan Vally Associate Professor, La Trobe University Hassan Vally, La Trobe University Last night, the federal government announced substantially revised plans for …
Keeping up to date
A review of the recent changes to prescription medicine listings and new product listings Our monthly review of medicine listing changes, from MIMS Australia New Products Budesonide (Jorveza) is a …
Psychostimulants: do you know the rules?
Are you aware of your obligations regarding the supply of psychostimulants? PDL NSW has issued an update… PDL receives numerous reports and queries relating to the specific rules on correctly …
Freedom fight
Sarah Stoddart explores this pharmacy’s challenge to the exercise of ministerial discretion The Federal Court of Australia has dismissed an application challenging the Minister for Health’s discretionary power to approve …
To embed, or not to embed
The AJP Debate: the case for, and against, having pharmacists embedded within aged care settings or GP clinics EMBEDDED PHARMACISTS – The argument for: by Mark Naunton You might not …
